Antunes F
Study of the epidemiology of Pneumocystis carinii f. sp. suis in abattoir swine in Portugal
- Autores: Antunes F, Esgalhado R, Esteves F, Matos O
- Ano de Publicação: 2013
- Journal: Medical Mycology
- Link: http://www.ncbi.nlm.nih.gov/pubmed/22852751
Pneumocystis has been identified in various mammalian species, including domestic, wild and zoo animals. This study’s main objectives were: (1) to estimate the prevalence of the Pneumocystis carinii f. sp. suis infection in slaughtered pigs in Portugal, (2) assess the prevalence differences within distinct age groups of animals, (3) determine the possible associations between pulmonary lesions and the infection, and (4) genetically characterize the P. carinii f. sp. suis isolates recovered from infected animals using PCR with DNA sequencing.
Ler mais
Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers
- Autores: Antunes F, Badura R, CALDERÓN E. J., CALÉ S. S., DE BOER M. G., Esteves F, Maltez F, MARQUEZ-MARTIN E., Matos O, VAN DER REIJDEN T. J.
- Ano de Publicação: 2015
- Journal: Clinical microbiology and infection
- Link: http://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)00111-6/abstract
This study aimed to assess the usefulness of (1–3)-β-d-glucan (BG), Krebs von den Lungen-6 antigen (KL-6), lactate dehydrogenase (LDH) and S-adenosyl methionine (SAM) as serologic biomarkers in the diagnosis of PCP.
Ler mais
Microsporidia as emerging pathogens and the implication for public health: a 10-year study on HIV-positive and -negative patients.
- Autores: Antunes F, Lobo ML, Matos O, Xiao L
- Ano de Publicação: 2012
- Journal: International Journal for Parasitology
- Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Microsporidia+as+emerging+pathogens+and+the+implication+for+public+health%3A+A+10-year+study+on+HIV-positive+and+-negative+patients.
Despite recent advances in the understanding and diagnosis of emerging microsporidian pathogens, more research is necessary to elucidate their complex epidemiology. In fact, studies that reflect true human-infecting microsporidian prevalence are still inadequate. The present 10-year study was undertaken to examine the occurrence of Microsporidia in 1989 stools, 69 urine and 200 pulmonary specimens from HIV-positive and HIV-negative patients using PCR and DNA sequencing.
Ler mais
Multicentre study highlighting clinical relevance of new high-throughput methodologies in molecular epidemiology of Pneumocystis jirovecii pneumonia
- Autores: Antunes F, Badura R, BASSAT Q., CALDERÓN E. J., de Armas Y, de Sousa B, Esteves F, HUANG L., Maltez F, Matos O
- Ano de Publicação: 2016
- Journal: Clinical microbiology and infection
- Link: https://www.ncbi.nlm.nih.gov/pubmed/27021425
Pneumocystis jirovecii causes severe interstitial pneumonia (PcP) in immunosuppressed patients. This multicentre study assessed the distribution frequencies of epidemiologically relevant genetic markers of P. jirovecii in different geographic populations from Portugal, the USA, Spain, Cuba and Mozambique, and the relationship between the molecular data and the geographical and clinical information, based on a multifactorial approach.
Ler mais
Therapeutic Potential of Caspofungin Combined with Trimethoprim-Sul- famethoxazole for Pneumocystis Pneumonia: A Pilot Study in Mice
- Autores: Antunes F, Cardoso F, Cushion MT, de Sousa B, Esteves F, Lobo ML, Matos O
- Ano de Publicação: 2013
- Journal: PLoS One
- Link: http://www.ncbi.nlm.nih.gov/pubmed/23940606
Pneumocystis pneumonia (PcP) is a major cause of mortality and morbidity in immunocompromised patients. There are limited alternative therapeutic choices to trimethoprim-sulfamethoxazole (TMP-SMX) which is the standard first line therapy/prophylaxis for PcP.
Ler mais
Pneumocystis jirovecii multilocus genotyping in pooled DNA samples: a new approach for clinical and epidemiological studies.
- Autores: Antunes F, de Sousa B, Esteves F, Gaspar J, Mansinho K, Matos O
- Ano de Publicação: 2012
- Journal: Clinical microbiology and infection
- Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Pneumocystis+jirovecii+multilocus+genotyping+in+pooled+DNA+samples%3A+a+new+approach+for+clinical+and+epidemiological+studies.
Specific single-nucleotide polymorphisms (SNPs) are recognized as important DNA sequence variations influencing the pathogenesis of Pneumocystis jirovecii and the clinical outcome of Pneumocystis pneumonia, which is a major worldwide cause of illness among immunocompromised patients
Ler mais
Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients
- Autores: Antunes F, Esteves F, Gaspar J, Mansinho K, Matos O, Moser I, Tavares A
- Ano de Publicação: 2010
- Journal: Infection Genetics and Evolution
- Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Population+structure+of+Pneumocystis+jirovecii+isolated+from+immunodeficiency+virus+positive+patients
Pneumocystis jirovecii pneumonia (PcP) is an important opportunistic infection among immunocompromised patients. Genetic characterization of P. jirovecii isolated from HIV-positive patients, based on identification of multiple nucleotide sequences at eight distinct loci, was achieved by using PCR with DNA sequencing and RFLP.
Ler mais
Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data
- Autores: Antunes F, Esteves F, Gaspar J, Leite R, Mansinho K, Marques T, Matos O
- Ano de Publicação: 2010
- Journal: Clinical microbiology and infection
- Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Identification+of+relevant+Single+Nucleotide+Polymorphisms+in+Pneumocystis+jirovecii%3A+relationship+with+clinical+data
Pneumocystis jirovecii is a poorly understood pathogen that causes opportunistic pneumonia (Pneumocystis pneumonia (PcP)) in patients with AIDS.
Ler mais
Baseline susceptibility of primary HIV-2 to entry inhibitors.
- Autores: Antunes F, Barroso H, Bártolo I, Borrego P, Caixas U, Calado R, Cavaco-Silva P, Doroana M, Maltez F, Marcelino JM, Rocha C, Taveira N
- Ano de Publicação: 2012
- Journal: Antiviral Therapy
- Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Baseline+susceptibility+of+primary+HIV-2+to+entry+inhibitors
BACKGROUND:
The baseline susceptibility of primary HIV-2 to maraviroc (MVC) and other entry inhibitors is currently unknown.
Ler mais